Results 11 to 20 of about 31,395 (237)

Plexiform Neurofibroma

open access: yesRadioGraphics
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Shehbaz Ansari   +4 more
wiley   +4 more sources

Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage

open access: yesJournal of Pharmacology and Experimental Therapeutics, 2023
Individuals with neurofibromatosis type 1 develop rat sarcoma virus (RAS)–mitogen-activated protein kinase–mitogen-activated and extracellular signal-regulated kinase (RAS-MAPK-MEK)–driven nerve tumors called neurofibromas.
Mark Jackson   +14 more
semanticscholar   +1 more source

Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma.

open access: yesClinical Cancer Research, 2023
PURPOSE Plexiform neurofibromas (PNF) are peripheral nerve sheath tumors that cause significant morbidity in persons with neurofibromatosis type 1 (NF1), yet treatment options remain limited.
Alyssa C Flint   +23 more
semanticscholar   +1 more source

Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene

open access: yesInternational Journal of Molecular Sciences, 2023
Plexiform neurofibromas occurring in approximately 20–50% of all neurofibromatosis type-1 (NF1) cases are histologically benign tumors, but they can be fatal due to compression of vital structures or transformation to malignant sarcomas or malignant ...
K. Veres   +7 more
semanticscholar   +1 more source

Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment

open access: yesJCI Insight, 2022
To define alterations early in tumor formation, we studied nerve tumors in neurofibromatosis 1 (NF1), a tumor predisposition syndrome. Affected individuals develop neurofibromas, benign tumors driven by NF1 loss in Schwann cells (SCs).
Leah J. Kershner   +7 more
semanticscholar   +1 more source

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial. [PDF]

open access: yesNat Med
Gross AM   +34 more
europepmc   +2 more sources

Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA

open access: yesChild's Nervous System, 2022
To assess clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibroma (PN) in the USA. NF1-PN patients aged 8–18 years (treatment-naïve or ≤ 1 month of selumetinib treatment) and their caregivers
Xiaoqin Yang   +6 more
semanticscholar   +1 more source

A Case Series of Plexiform Neurofibroma: The Unusual Presentations and Surgical Challenges

open access: yesCureus, 2022
Neurofibromatosis type one (NF-1) is an autosomal dominant neurocutaneous disorder also known as Von Recklinghausen disease. Plexiform neurofibroma is a rare kind of NF-1 where the neurofibroma originates from nerve sheath cells or subcutaneous ...
Hui Yuan Lam   +1 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy